FEB 24, 2016 10:00 AM PST

Harnessing the Power of Healthcare Data with Causal Machine Learning to drive Personalized and Effective Treatment Interventions

C.E. CREDITS: P.A.C.E. CE
Speakers
  • Co-founder and executive vice president, GNS Healthcare
    Biography
      Iya Khalil, co-founder and executive vice president of GNS, has promoted use of the Cambridge, MA-based company's technology in the biopharma industry. One of the inventors of the company's computational platform, her work has helped major players such as Biogen Idec and Johnson & Johnson to make computer-driven discoveries for their respective R&D programs.

      Biopharma companies' lack of biological understanding explains a great many miserable failures in drug development. GNS' approach, known as reverse engineering/forward simulation, is able to crunch billions of genomic, molecular and clinical data points and identify cause-and-effect relationships. Such insights help pinpoint predictive biomarkers for experimental drugs and new targets for therapies.

      Khalil has pushed personalized medicine toward reality for more than a decade. She and GNS CEO Colin Hill started the company more than 11 years back while Khalil was wrapping up her Ph.D. in theoretical physics at Cornell University, and she has been at the forefront of integrating computational biology into the drug development process.

    Abstract:

    Every day, vast amounts of healthcare data are collected from clinical trials as well as real world medical visits on patient treatment regimens and subsequent clinical outcomes. This big data raw material provides a rich asset to investigate for understanding therapeutic effectiveness and patient care. Datasets range from genomics and other ‘omic data to clinical to medical and pharmacy claims to electronic medical records to registries and beyond, and analysis can discover and predict biomarkers, drivers of disease, novel interventions, mechanisms of action, drug combinations, disease models, portfolio optimization, and personalized care/treatment algorithms. Key to leveraging this data and uncovering which treatments and interventions specifically improve a patient’s health, are powerful analytic approaches. Utilizing causal mathematics and machine learning to create in silico disease networks directly from data has been a successful approach to identify predictive and causal mechanistic associations. Simulations of resultant models unlock the knowledge within complex data, enabling personalized, actionable predictions and precision targeting of interventions. Fully realizing the power of precision medicine to identify and predict patient outcomes will significantly increase the ability of healthcare leaders and professionals to make better decisions to improve patient care.

    The seminar will focus on the following learning objectives: [1] case studies detailing the data and experimental design that have yielded success and [2] key actionable insights generated from models and analytics that can be leveraged in drug discovery and development all the way to healthcare patient setting.
     


    Show Resources
    You May Also Like
    SEP 05, 2019 04:00 PM CEST
    C.E. CREDITS
    SEP 05, 2019 04:00 PM CEST
    DATE: September 5, 2019TIME: 7:00am PT, 10:00am ET, 4:00pm CEST PCR (Polymerase Chain Reaction) has gone through a massive evolution since its development in 1983. Besides it...
    AUG 27, 2019 09:00 AM PDT
    C.E. CREDITS
    AUG 27, 2019 09:00 AM PDT
    DATE: August 27, 2019 TIME: 9:00am PDT, 12:00pm EDT Immunotherapies targeting PD-1 or PD-L1 have proven remarkably effective for treating cancer in some patients, with considerabl...
    JUN 05, 2019 05:00 PM CEST
    C.E. CREDITS
    JUN 05, 2019 05:00 PM CEST
    DATE: June 5, 2019TIME: 8:00am PDT, 11:00am EDT, 5:00pm CEST Eukaryotic cell cultures respond to the most subtle influence. Apart from the risk of contamination, minimal chan...
    MAY 16, 2019 04:00 PM CEST
    C.E. CREDITS
    MAY 16, 2019 04:00 PM CEST
    DATE: May 16, 2019TIME: 7:00am PDT, 10:00am EDT, 4:00pm CEST The emergence of NGS is revolutionizing the microbiological sciences and transforming medicine. Deep sequencing has...
    NOV 18, 2019 07:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    NOV 18, 2019 07:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: November 18, 2019TIME: 7:00am PST, 11:00am EST, 4:00pm CEWT How often do you pipette in your cell culture lab every day? Usually, we do it so often that we tend stop th...
    OCT 02, 2019 11:00 AM PDT
    OCT 02, 2019 11:00 AM PDT
    DATE: October 2, 2019TIME: 11:00am PDT, 2:00pm EDT Ditch the Excel spreadsheets and manage your molecular workflows entirely in your LIMS Achieve configuration of molecular workf...
    Loading Comments...
    Show Resources